$0.86 0.00 (0.082%) Lexicon Pharmaceuticals Inc - NASDAQ

Dec. 17, 2014 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
12/12/2014Invus C.V.Senior Executive Officer150,000$0.880.50%
12/10/2014Invus C.V.Senior Executive Officer315,896$0.901.06%
2/28/2014SANDS ARTHUR TPresident & CEO-29,791$1.92-2.83%
2/28/2014Lapuerta PabloEVP, Clin Dev and CMO-11,992$1.92-30.93%
2/28/2014MAIN ALAN JEVP, Pharmaceutical Research-18,668$1.92-11.31%
2/28/2014Tessmer James FVP, Finance & Accounting-6,612$1.92-9.69%
2/28/2014ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-18,186$1.92-6.13%
2/28/2014WADE JEFFREY LEVP, Corp Dev and CFO-16,297$1.92-9.81%
2/28/2013ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-11,692$1.98-4.76%
2/28/2013WADE JEFFREY LEVP, Corp Dev and CFO-10,461$1.98-8.62%
2/28/2013Tessmer James FVP, Finance & Accounting-3,807$1.98-7.35%
2/28/2013SANDS ARTHUR TPresident & CEO-20,034$1.98-2.08%
2/28/2013Lapuerta PabloEVP, Clin Dev and CMO-4,725$1.98-36.35%
2/28/2013MAIN ALAN JEVP, Pharmaceutical Research-12,572$1.98-9.87%
1/31/2013WADE JEFFREY LEVP, Corp Dev and CFO-10,317$2.11-11.05%
1/31/2013SANDS ARTHUR TPresident & CEO-21,434$2.11-2.35%
1/31/2013ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-13,499$2.11-6.23%
1/31/2013Tessmer James FVP, Finance & Accounting-4,310$2.11-10.29%
1/31/2013MAIN ALAN JEVP, Pharmaceutical Research-12,537$2.11-11.81%
10/23/2012Invus, CVSenior Executive Officer3,000,000$2.251.07%
10/23/2012Artal International S.C.A.Senior Executive Officer3,000,000$2.251.07%
2/28/2012Tessmer James FVP, Finance & Accounting-2,299$1.78-7.42%
2/28/2012MAIN ALAN JEVP, Pharmaceutical Research-5,907$1.78-9.20%
2/28/2012WADE JEFFREY LEVP, Corp Dev and CFO-4,959$1.78-7.43%
2/28/2012ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-5,621$1.78-3.12%
2/28/2012SANDS ARTHUR TPresident & CEO-9,588$1.78-1.13%
12/22/2011Ulys, LLCSenior Executive Officer113,382,063$1.1382.77%
12/22/2011Ulys, LLCSenior Executive Officer1,622,184$1.1341.27%
12/22/2011MAIN ALAN JEVP, Pharmaceutical Research19,211$1.1342.72%
12/22/2011BARKER SAM LDirector34,000$1.1351.52%
12/22/2011SANDS ARTHUR TPresident & CEO25,000$1.133.18%
2/23/2011MAIN ALAN JEVP, Pharmaceutical Research-5,926$1.81-11.64%
2/23/2011Tessmer James FVP, Finance & Accounting-2,116$1.81-8.27%
2/23/2011SANDS ARTHUR TPresident & CEO-10,464$1.81-1.31%
2/23/2011WADE JEFFREY LEVP, Corp Dev and CFO-5,926$1.81-10.99%
2/23/2011ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-7,881$1.81-4.73%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LXRX), click here.
Trading Center